84
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Subperiosteal inflammatory pseudotumor mimicking primary malignant bone tumor: A case report

, , , , , & show all
Pages 369-371 | Received 17 Jun 2014, Accepted 23 Sep 2014, Published online: 10 Nov 2014

References

  • Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2011;22(1): 1–14.
  • Stone JH, Zen Y, Deshpande V.IgG4-related disease. N Engl J Med. 2012;366(6):539–51.
  • Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36(7):710–7.
  • Mizushima I, Yamada K, Fujii H, Inoue D, Umehara H, Yamagishi M, et al. Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol. 2012;22(6):859–70.
  • Narla LD, Newman B, Spottswood SS, Narla S, Kolli R. Inflammatory pseudotumor. Radiographics. 2003;23(3):719–29.
  • Whiley RA, Beighton D, Winstanley TG., Fraser HY, Hardie JM. Streptococcus intermedius, Streptococcus constellatus, Streptococcus anginosus (the Streptococcus milleri group): Association with different body sites and clinical infections. J Clin Microbiol. 1992; 30(1):243–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.